Factory 99% Atovaquone Powder CAS 95233-18-4 Antiprotozoal Atovaquone

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A630
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Atovaquone
• CAS: 95233-18-4
• Appearance: Yellow Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 1g
• Function: Antiprotozoal
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

 

Product Name	Atovaquone
Appearance	Yellow Powder
CAS NO.	95233-18-4
MF	C22H19ClF3N3O3
Storage	Keep in a cool, dry, dark location

 

Atovaquone is an oral medication primarily used to treat and prevent certain protozoal infections. It works by inhibiting the electron transport chain in the mitochondria of the parasites, thereby disrupting their energy metabolism and leading to their death.

 

1. Treatment of Protozoal Infections: It is prescribed for the treatment of Pneumocystis jirovecii pneumonia in patients with HIV/AIDS and for the prevention and treatment of malaria caused by Plasmodium falciparum.
2. Combination Therapy: Often used in combination with other drugs to enhance its efficacy and broaden its spectrum of activity against different protozoal species.
3. Prophylaxis: Administered as a prophylactic agent to prevent the occurrence of protozoal infections in high-risk individuals, such as those traveling to malaria-endemic areas.

1. Antiprotozoal Activity: Atovaquone's primary function is to inhibit the growth and reproduction of protozoa by interfering with their energy production processes.
2. Broad-Spectrum Activity: It demonstrates activity against a wide range of protozoal species, making it a versatile treatment option for various infections.
3. Oral Administration: Its oral formulation allows for convenient and effective administration, improving patient compliance and treatment outcomes.